MAPT and supranuclear palsy, progressive, 1: Since, tau aggregates in PSP are mainly consistent of 4-repeat tau, another therapeutical approach would be to modify the splicing process of MAPT, to shift the presence of tau-protein from 4-repeat- to 3-repeat isoforms.